Real-world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study

Further Publications

Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosis

Eur Heart J

Nitsche C, Dobner S, Rosenblum HR, Patel KP, Longhi S, Yilmaz A, Merlo M, Papathanasiou M, Griffin J, Oerlemans MIFJ, Gama F, Hamdan A, Kelion AD, Schuster A, Glaveckaité S, Akyol N, Porcari A, Schlender L, Capovilla T, Autherith M, Hauptmann L, Halavina K, Cavalcante JL, Fontana M, Scully PR, Moon JC, Mascherbauer J, Ristl R, Biagini E, Stortecky S, Maurer MS, Treibel TA, AS-Amyloidosis Consortium

doi: 10.1093/eurheartj/ehaf362

Cardiac Arrest or Death

Early point-of-care echocardiography as a predictive factor for absence of return of spontaneous circulatory in out-of-hospital cardiac arrests: a multicentre observational study

Resuscitation

Javaudin F, Papin M, Le Bastard Q, Thibault M, Boishardy T, Brau F, Laribi S, Petrovic T, Peluchon T, Markarian T, Volteau C, Arnaudet I, Pes P, Le Conte P

doi: 10.1016/j.resuscitation.2024.110373

Heart Failure

Real-world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registry

ESC Heart Fail

García-Bolao I, Gardner RS, Gras D, D'Onofrio A, Mark G, Nair D, Lellouche N, Novak M, Lo R, Chew E, Wright D, Kaplan A, Bertini M, Veraghtert S, Harbin MM, Matznick E, Yong P, Stein KM

doi: 10.1002/ehf2.15190

Heart Failure

Real-world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: The RED-HEART study

ESC Heart Fail

Kocabas U, Ergin I, Yavuz V, Altın C, Kaplan M, Yılmaz Öztekin GM, Doğduş M, Murat S, Murat B, Kıvrak T, Karabulut D, Kaya E, Özdemir İH, Yıldız C, Salkın FÖ, Özçalık E, Polatkan ŞG, Çakan F, Şen T, Karabulut U, Çakal S, Oflar E, Sinan ÜY, Yenerçağ M, Türk UÖ

doi: 10.1002/ehf2.15049

Cardiac Arrest or Death

The Impact of Real-Time Feedback on Ventilation Quality During Out-of-Hospital Cardiac Arrest: A Before-and-After Study

Resuscitation

Drennan IR, Lee M, Héroux JP, Lee A, Riches J, Peppler J, Poitras A, Cheskes S

doi: 10.1016/j.resuscitation.2024.110381

Further Publications

Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis

Eur J Heart Fail

Muller SA, Peiró-Aventin B, Biagioni G, Tini G, Saturi G, Kronberger C, Achten A, Dobner S, Te Rijdt WP, Gasperetti A, Te Riele ASJM, Varrà GG, Ponziani A, Hirsch A, Porcari A, van der Meer MG, Zampieri M, van der Harst P, Kammerlander A, Biagini E, van Tintelen JP, Barbato E, Asselbergs FW, Menale S, Gräni C, Merlo M, Michels M, Knackstedt C, Nitsche C, Longhi S, Musumeci B, Cappelli F, Garcia-Pavia P, Oerlemans MIFJ

doi: 10.1002/ejhf.3339

Further Publications

Cardiac implantable electronic device carriers undergoing transcatheter tricuspid valve annuloplasty: real-world insights

Clin Res Cardiol

Wrobel JM, Kirchner J, Friedrichs K, Gietzen T, Althoff J, Hasse C, von Stein P, Wörmann J, von Stein J, Curio J, Rudolph F, Ivannikova M, Iliadis C, Steven D, Baldus S, Rudolph V, Pfister R, Gerçek M, Koerber MI

doi: 10.1007/s00392-025-02616-5

Heart, Artery and Coronary Diseases

Association between SSRI use and cardiovascular outcomes in patients with coronary artery disease and generalized anxiety disorder: A real-world cohort study

Atherosclerosis

Wu JY, Chang HY, Kao CL, Hung KC, Yu T, Lin YM

doi: 10.1016/j.atherosclerosis.2025.120390

Heart, Artery and Coronary DiseasesTherapy and Intervention

The Reversibility of Cardiac Damage After Transcatheter Aortic Valve Implantation and Short-Term Outcomes in a Real-World Setting

Eur Heart J Cardiovasc Imaging

Myagmardorj R, Fortuni F, Généreux P, Nabeta T, Stassen J, Galloo X, Meucci MC, Butcher S, van der Kley F, Cohen DJ, Clavel MA, Pibarot P, Leon MB, Regeer MV, Delgado V, Ajmone Marsan N, Bax JJ

doi: 10.1093/ehjci/jeaf045

Related content

Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosis

Early point-of-care echocardiography as a predictive factor for absence of return of spontaneous circulatory in out-of-hospital cardiac arrests: a multicentre observational study

Real-world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registry

Real-world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: The RED-HEART study

The Impact of Real-Time Feedback on Ventilation Quality During Out-of-Hospital Cardiac Arrest: A Before-and-After Study

Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis

Cardiac implantable electronic device carriers undergoing transcatheter tricuspid valve annuloplasty: real-world insights

Association between SSRI use and cardiovascular outcomes in patients with coronary artery disease and generalized anxiety disorder: A real-world cohort study

The Reversibility of Cardiac Damage After Transcatheter Aortic Valve Implantation and Short-Term Outcomes in a Real-World Setting